Skip to content
10-Q

Quarterly Report

AVAI BIO, INC. AVAI

0001740797-26-000009

← back to feed
Filed
Feb 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Feb 12, 2026 138.25M sh
Operating Cash Flow Q3 2026 · Dec 31, 2025 −$959.02K
Operating Cash Flow Q3 2026 · Dec 31, 2024 −$973.11K
Cash And Equivalents Q3 2026 · Dec 31, 2025 $50.4K
Cash And Equivalents Q3 2026 · Mar 31, 2025 $81.05K
Stockholders Equity Q3 2026 · Dec 31, 2025 −$2.79M
Stockholders Equity Q3 2026 · Sep 30, 2025 −$2.3M
Stockholders Equity Q3 2026 · Jun 30, 2025 −$1.99M
Stockholders Equity Q3 2026 · Mar 31, 2025 −$1.56M
Current Liabilities Q3 2026 · Dec 31, 2025 $2.97M
Current Liabilities Q3 2026 · Mar 31, 2025 $1.79M
Total Liabilities Q3 2026 · Dec 31, 2025 $2.97M
Total Liabilities Q3 2026 · Mar 31, 2025 $1.79M
Current Assets Q3 2026 · Dec 31, 2025 $60.85K
Current Assets Q3 2026 · Mar 31, 2025 $93.13K
Total Assets Q3 2026 · Dec 31, 2025 $172.91K
Total Assets Q3 2026 · Mar 31, 2025 $224.75K
Eps Basic Q3 2026 · Dec 31, 2025 $0.00
Eps Basic Q3 2026 · Dec 31, 2025 −$0.01
Eps Basic Q3 2026 · Dec 31, 2024 $0.00
Eps Basic Q3 2026 · Dec 31, 2024 −$0.01
Sga Expense Q3 2026 · Dec 31, 2025 $190.12K
Sga Expense Q3 2026 · Dec 31, 2025 $600.03K
Sga Expense Q3 2026 · Dec 31, 2024 $259.97K
Sga Expense Q3 2026 · Dec 31, 2024 $937.48K
Rd Expense Q3 2026 · Dec 31, 2025 $23.8K
Net Income Q3 2026 · Dec 31, 2025 −$553.73K
Net Income Q3 2026 · Sep 30, 2025 −$453.02K
Net Income Q3 2026 · Jun 30, 2025 −$487.59K
Net Income Q3 2026 · Dec 31, 2024 −$452.3K
Net Income Q3 2026 · Sep 30, 2024 −$625.05K
Net Income Q3 2026 · Jun 30, 2024 −$528.84K
Operating Income Q3 2026 · Dec 31, 2025 −$553.73K
Operating Income Q3 2026 · Dec 31, 2025 −$1.49M
Operating Income Q3 2026 · Dec 31, 2024 $452.3K
Operating Income Q3 2026 · Dec 31, 2024 $1.61M